Strive, Inc. provides investment advisory and structured finance services. The company operates through three segments: Asset Management, Medical Device, and Corporate and Other. The Asset Management segment provides investment advisory services and acts as sub-advisor to a series of exchange-traded funds, with products offered through exchange-traded funds and separate accounts. The Medical Device segment sells medical devices, generating revenue from software licensing, fee-per-test arrangements, and hardware sales. The Corporate and Other segment maintains a Bitcoin treasury strategy, acquiring and holding Bitcoin as a primary reserve asset, and issues preferred equity securities, including SATA and SATS. The company also operates an at-the-market equity program for continuous issuance of Class A common stock and SATA preferred stock. Strive, Inc. was formerly known as Asset Entities Inc. and changed its name to Strive, Inc. in September 2025. Strive, Inc. was incorporated in 2022 and is based in Dallas, Texas.…
Can Strive (ASST) Still Look Reasonable After Its 45% Fall?
Strive (NASDAQ: ASST) is listed on Nasdaq, where its shares trade in USD. It belongs to the Asset Management industry, part of the Financial Services sector, and reports about 28 employees.
The shares were at 14.51 USD on 20 November 2026, down 52.0% over 52 weeks. Its 52-week range is 7.020 USD to 34.40 USD: the price is 57.8% below the high and 106.7% above the low.
Its market capitalisation is 1.85B USD.
Strive reports return on equity of -3.0% and revenue up 74.7% year over year.
It holds more cash than debt, a net cash position of 332.36M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 5 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 40.60 USD is 179.8% above the current price. The next earnings report is expected on 18 March 2027.